Boehringer Ingelheim Venture Fund (BIVF)
Investor profile
Investment firmVenture capital
Also recorded as: the Boehringer Ingelheim Venture Fund (BIVF)
Deals
5
distinct rounds
Companies
5
backed
Active span
2022–2026
5 yrs
Total round €
€52M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Brainomix | UK | 1 | €17M |
| Aignostics | Germany | 1 | €14M |
| tacalyx | Germany | 1 | €11M |
| Refoxy Pharmaceuticals | Germany | 1 | €9.1M |
| smartbax | Germany | 1 | €1.2M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Brainomix | Series C | €17M | 2025-03 |
| Aignostics | Series A | €14M | 2022-09 |
| tacalyx | Seed | €11M | 2026-04 |
| Refoxy Pharmaceuticals | Seed | €9.1M | 2024-12 |
| smartbax | Seed | €1.2M | 2023-05 |